Conzerol
NDC Package 72383-000-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Conzerol is molluscum Contagiosum lesion relief. Marketed by Discovery Pharma Sp Z O O, this product is identified by NDC 72383-000.

Identification & Billing

NDC Package Code
72383-000-01
Package Description
28 g in 1 TUBE
Product Code
72383-000
11-Digit Billing Format
72383000001

Clinical Specifications

Proprietary Name
Conzerol
Dosage Form
-
Usage Information
Molluscum Contagiosum lesion relief

Regulatory & Marketing

Labeler Name
Discovery Pharma Sp Z O O
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
05-30-2018
Listing Expiration
12-31-2022
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 72383-000-01 identifies a specific commercial package of 28 g in 1 tube of Conzerol, labeled by Discovery Pharma Sp Z O O. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Discovery Pharma Sp Z O O on May 30, 2018. The current certification is valid through December 31, 2022.

How is this Discovery Pharma Sp Z O O product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72383000001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
72383-000-01
11-Digit CMS (5-4-2)
72383-0000-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.